Literature DB >> 32562538

Social Distancing Measures: Evidence of Interruption of Seasonal Influenza Activity and Early Lessons of the SARS-CoV-2 Pandemic.

Andrew D Wiese1, Jordan Everson1, Carlos G Grijalva1.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; influenza; influenza-like-illness; social distancing; surveillance

Mesh:

Year:  2021        PMID: 32562538      PMCID: PMC7337694          DOI: 10.1093/cid/ciaa834

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
( The unprecedented enactment of social-distancing measures in response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic—including city lockdowns, school closures, stay-at-home orders, case isolation, quarantine of contacts, etc—was aimed at reducing the transmission of the virus and its burden on healthcare systems. Since influenza and other common respiratory pathogens share a similar mode of transmission with SARS-CoV-2, their transmission could be indirectly impacted by those measures. And while novel surveillance systems have been implemented to monitor SARS-CoV-2 activity, pre-existing surveillance systems have the advantage of allowing comparison to trends in prior years to assess the impact of social-distancing measures on the activity of influenza and other respiratory pathogens. Syndromic surveillance is an important public health tool for the early detection, monitoring, and characterization of outbreaks and supports targeted investigations that may include detailed clinical and laboratory assessments. Syndromic surveillance is especially informative when diagnostic tests are not available, applied selectively, or difficult to implement on a broad scale. Globally, syndromic surveillance systems of influenza-like illness (ILI) are maintained to characterize the onset, circulation, and characteristics of influenza activity. These activities are typically complemented with surveillance of laboratory-confirmed detection of influenza infections. Maintained over multiple years, these surveillance systems help identify syndromic and viral activity that deviates from previous years’ patterns. In this issue of Clinical Infectious Diseases, Hyunju Lee and colleagues describe the use of national influenza surveillance data to assess the impact of social-distancing measures, implemented in response to the SARS-CoV-2 pandemic, on seasonal influenza activity in Korea [1]. Previous reports have demonstrated that the implementation of social-distancing measures was associated with reductions in SARS-CoV-2 infections [2-4]. In this study, investigators compared the distribution of circulating influenza viruses, duration of the epidemics, patterns of ILI activity, and hospitalizations between the current 2019–2020 influenza season and previous seasons. The study shows that, during the period of enforced social distancing, the current influenza season terminated earlier than anticipated and ILI activity and influenza-related hospitalizations were reduced relative to previous seasons. This work complements previous reports from Singapore, Hong Kong, China, Taiwan, and Japan in which the successful implementation of social-distancing measures led to reductions in SARS-CoV-2 activity and to substantial declines in influenza activity compared with prior influenza seasons [5-9]. The well-organized and determined community and public health responses in these regions and countries, including Korea, now serve as models for the pandemic response elsewhere. In the United States, the Centers for Disease Control and Prevention conducts surveillance of influenza and other respiratory infections. Publicly available viral and syndromic surveillance data can be used to examine the impact of social-distancing measures and compute (1) the weekly percentage of total respiratory specimens that test positive for influenza type A and B, (2) the weekly percentage of visits among outpatient providers with evidence of fever with either a cough or sore throat (ILI), and (3) the weekly percentage of emergency department visits with evidence of a coronavirus diagnosis code or fever with either of the following: cough, shortness of breath, or difficulty breathing (coronavirus disease 2019 [COVID-19]–like illness [CLI]) [10]. Prior to enactment of social-distancing measures, the median weekly percentage of influenza positive specimens was elevated in 2019–2020 (Figure 1A) relative to weekly median historic levels nationally (2015–2019) and in 8 human health services (HHS) regions (Figure 1B). After social-distancing implementation, the percentage was substantially lower than historical levels nationally and in every region (Figure 1B). The percentage of encounters with ILI was elevated relative to historical levels nationally and in every region prior to social-distancing enactment. However, since social-distancing enactment (as of 4 July 2020), the national ILI level returned to historical levels, although following the recent relaxation of social distancing measures ILI started increasing again in certain regions, including the Atlanta, Dallas, Kansas City, and Seattle regions (Figure 1B). For the more specific COVID-19–related syndromic surveillance, the percentage of encounters with CLI did not increase substantially until March (Figure 1). Similar to ILI, COVID-19–like illnesses had declined following enactment of social distancing, although the decline lagged relative to the observed ILI decline. CLI activity also started increasing in several regions during the last weeks.
Figure 1.

A, National current weekly percentage of influenza-positive respiratory specimens and ILI- and CLI-related outpatient encounters in the United States (2015–2020). B, Regional current and historical weekly percentage of influenza-positive respiratory specimens and ILI- and CLI-related outpatient encounters in the United States (2015–2020). Notes: Influenza positive (blue solid lines), ILI (green solid lines), and CLI (black dashed lines) (2019–2020): the value for each week during the 2019–2020 viral respiratory season. Influenza-positive (red solid lines), ILI (orange solid lines) (2015–2019): the median value for each week in the prior 4 influenza seasons (2015–2019). Surveillance data sources: Laboratory-confirmed influenza compiled from NREVSS and WHO Collaborating Laboratory surveillance data, ILI compiled from ILInet, and CLI compiled from the National Syndromic Surveillance Program. Regions: Defined based on the US Health and Human Services regions: 1-Boston—Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont; 2-New York—New Jersey, New York, Puerto Rico, Virgin Islands; 3-Philadelphia—Delaware, Washinton DC, Maryland, Pennsylvania, Virginia, West Virginia; 4-Atlanta—Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; 5-Chicago—Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; 6-Dallas—Arkansas, Louisiana, New Mexico, Oklahoma, Texas; 7-Kansas City—Iowa, Kansas, Missouri, Nebraska; 8-Denver—Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; 9-San Francisco—Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Marshall Islands, and Republic of Palau; 10-Seattle—Alaska, Idaho, Oregon, Washington. 1Social distancing enactment: The period before the enactment of social distancing at the regional level was measured as the time prior to and including the week of the first statewide school closure or mass gathering restriction for each region. Abbreviations: CLI, Covid-like illness; Covid, coronavirus disease; ILI, influenza-like illness; WHO, World Health Organization.

A, National current weekly percentage of influenza-positive respiratory specimens and ILI- and CLI-related outpatient encounters in the United States (2015–2020). B, Regional current and historical weekly percentage of influenza-positive respiratory specimens and ILI- and CLI-related outpatient encounters in the United States (2015–2020). Notes: Influenza positive (blue solid lines), ILI (green solid lines), and CLI (black dashed lines) (2019–2020): the value for each week during the 2019–2020 viral respiratory season. Influenza-positive (red solid lines), ILI (orange solid lines) (2015–2019): the median value for each week in the prior 4 influenza seasons (2015–2019). Surveillance data sources: Laboratory-confirmed influenza compiled from NREVSS and WHO Collaborating Laboratory surveillance data, ILI compiled from ILInet, and CLI compiled from the National Syndromic Surveillance Program. Regions: Defined based on the US Health and Human Services regions: 1-Boston—Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont; 2-New York—New Jersey, New York, Puerto Rico, Virgin Islands; 3-Philadelphia—Delaware, Washinton DC, Maryland, Pennsylvania, Virginia, West Virginia; 4-Atlanta—Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; 5-Chicago—Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; 6-Dallas—Arkansas, Louisiana, New Mexico, Oklahoma, Texas; 7-Kansas City—Iowa, Kansas, Missouri, Nebraska; 8-Denver—Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; 9-San Francisco—Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Marshall Islands, and Republic of Palau; 10-Seattle—Alaska, Idaho, Oregon, Washington. 1Social distancing enactment: The period before the enactment of social distancing at the regional level was measured as the time prior to and including the week of the first statewide school closure or mass gathering restriction for each region. Abbreviations: CLI, Covid-like illness; Covid, coronavirus disease; ILI, influenza-like illness; WHO, World Health Organization. Although there are differences in the design and adoption of social-distancing measures across settings and populations, the consistency of the observed impact on the transmission of influenza, SARS-CoV-2, and likely other respiratory pathogens seems evident and intuitive. While many social-distancing measures are very disruptive and difficult to sustain, Lee and colleagues’ work underscores that basic principles of self-protection against respiratory infections, such as hand hygiene and cough etiquette, recommendations for persons with respiratory symptoms to stay at home until symptoms subside, and use of masks or cloth face covering in all cases of close person-to-person contact, rapidly adopted in response to the pandemic are becoming part of our lifestyle as we adapt to a “new normal.” The wide adoption and practice of these recommendations could lead to a new paradigm for the activity of SARS-CoV-2 and other respiratory infections in the near future, with lower activity compared with historical records. As we reflect on the suffering inflicted by the ongoing pandemic and we contemplate the relaxation of harsh social-distancing measures, the value of these simple, scalable, inexpensive common-sense measures may be the lesson that we all need to learn and adopt. While surveillance data are helpful to identify abnormal activity of certain diseases of public health interest, and to demonstrate the impact of major interventions, such as implementation of social-distancing measures, it is important to understand the limitations and strengths of specific surveillance systems. Monitoring a new disease that rapidly reaches pandemic proportions is difficult for surveillance systems that rely on patients presenting to healthcare settings and getting tested. Due to fear or other reasons, patients may avoid or delay healthcare encounters unless strictly necessary, and changes in testing practices could also affect the data captured by surveillance systems. Complementing laboratory-based surveillance with syndromic surveillance data is helpful, but additional research is necessary to clarify and characterize the general healthcare utilization patterns during the pandemic. In Korea, the United States, and most other settings, several social-distancing measures were implemented in rapid sequence, making it difficult to isolate the impact of specific measures due to their temporal and regional aggregation. Although the described comparisons are ecologic in nature, the population-level assessment of the impact of these broad recommendations may be more relevant than individual-level evaluations. Finally, it is important to understand that there may be substantive surveillance variation over time and across regions (Figure 1), and thus national figures may not represent the local or regional situation. Looking beyond influenza, these surveillance systems will be important in different regions and countries as they initiate or continue relaxing social-distancing requirements. In the United States, a 2-week downward trend in ILI and CLI activity was recommended as 1 indicator for reopening [11]. Despite declines following social distancing, CLI activity levels remained substantially elevated or started increasing in certain regions through the beginning of July 2020, suggesting that high activity levels could rapidly resume once distancing measures are removed. In contrast with the abrupt interruption of influenza activity, the lag time between social-distancing enactment and declines in CLI activity in certain regions highlights the differential SARS-CoV-2 transmission patterns relative to influenza. This delayed impact requires careful attention by policy makers considering the removal and subsequent reenactment of social-distancing measures. Influenza and syndromic surveillance data suggest that widespread social-distancing measures were effective at reducing influenza and SARS-CoV-2 activity in Korea and elsewhere. These surveillance data will remain important for monitoring the pandemic as social-distancing measures are relaxed.
  9 in total

1.  Impact of Public Health Interventions on Seasonal Influenza Activity During the COVID-19 Outbreak in Korea.

Authors:  Hyunju Lee; Heeyoung Lee; Kyoung-Ho Song; Eu Suk Kim; Jeong Su Park; Jongtak Jung; Soyeon Ahn; Eun Kyeong Jeong; Hyekyung Park; Hong Bin Kim
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

2.  Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan.

Authors:  Haruka Sakamoto; Masahiro Ishikane; Peter Ueda
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

3.  Non-pharmaceutical interventions used for COVID-19 had a major impact on reducing influenza in China in 2020.

Authors:  Jing Sun; Zhanli Shi; Hong Xu
Journal:  J Travel Med       Date:  2020-04-24       Impact factor: 8.490

4.  Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease.

Authors:  Laura Matrajt; Tiffany Leung
Journal:  Emerg Infect Dis       Date:  2020-04-28       Impact factor: 6.883

5.  Effect of non-pharmaceutical interventions to contain COVID-19 in China.

Authors:  Shengjie Lai; Nick W Ruktanonchai; Liangcai Zhou; Olivia Prosper; Wei Luo; Jessica R Floyd; Amy Wesolowski; Mauricio Santillana; Chi Zhang; Xiangjun Du; Hongjie Yu; Andrew J Tatem
Journal:  Nature       Date:  2020-05-04       Impact factor: 49.962

6.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.

Authors:  Benjamin J Cowling; Sheikh Taslim Ali; Tiffany W Y Ng; Tim K Tsang; Julian C M Li; Min Whui Fong; Qiuyan Liao; Mike Yw Kwan; So Lun Lee; Susan S Chiu; Joseph T Wu; Peng Wu; Gabriel M Leung
Journal:  Lancet Public Health       Date:  2020-04-17

7.  Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.

Authors:  Barbara Nussbaumer-Streit; Verena Mayr; Andreea Iulia Dobrescu; Andrea Chapman; Emma Persad; Irma Klerings; Gernot Wagner; Uwe Siebert; Claudia Christof; Casey Zachariah; Gerald Gartlehner
Journal:  Cochrane Database Syst Rev       Date:  2020-04-08

8.  Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.

Authors:  Roy Jiunn Jye Soo; Calvin J Chiew; Stefan Ma; Rachael Pung; Vernon Lee
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

9.  Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan.

Authors:  Shu-Chen Kuo; Shu-Man Shih; Li-Hsin Chien; Chao A Hsiung
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

  9 in total
  8 in total

1.  Infection control of COVID-19 in pediatric tertiary care hospitals: challenges and implications for future pandemics.

Authors:  Jonathan Remppis; Johannes Hilberath; Tina Ganzenmüller; Christoph Slavetinsky; Malte Kohns Vasconcelos; Marion Gnädig; Jan Liese; Siri Göpel; Peter Lang; Oliver Heinzel; Hanna Renk
Journal:  BMC Pediatr       Date:  2022-04-26       Impact factor: 2.567

2.  Changes in the incidence and clinical manifestations of paediatric respiratory infections of viral aetiology during the SARS-CoV-2 pandemic.

Authors:  David Díaz Pérez; Jordi Reina; Ricardo M Arcay; Borja Osona
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2022-05-13

3.  The COVID-19 Pandemic and Changes in Healthcare Utilization for Pediatric Respiratory and Nonrespiratory Illnesses in the United States.

Authors:  James W Antoon; Derek J Williams; Cary Thurm; Michael Bendel-Stenzel; Alicen B Spaulding; Ronald J Teufel; Mario A Reyes; Samir S Shah; Chén C Kenyon; Adam L Hersh; Todd A Florin; Carlos G Grijalva
Journal:  J Hosp Med       Date:  2021-05       Impact factor: 2.960

4.  Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: Likely role of lower transmission in the community.

Authors:  Fernanda Hammes Varela; Marcelo Comerlato Scotta; Márcia Polese-Bonatto; Ivaine Tais Sauthier Sartor; Charles Francisco Ferreira; Ingrid Rodrigues Fernandes; Gabriela Oliveira Zavaglia; Walquiria Aparecida Ferreira de Almeida; Denise Arakaki-Sanchez; Leonardo Araújo Pinto; Gisele Alsina Nader Bastos; Luiz Antônio Nasi; Maicon Falavigna; Paulo Márcio Pitrez; Renato T Stein
Journal:  J Glob Health       Date:  2021-03-01       Impact factor: 4.413

5.  Increased mask adherence after important politician infected with COVID-19.

Authors:  Deborah A Cohen; Meghan Talarowski; Olaitan Awomolo; Bing Han; Stephanie Williamson; Thomas L McKenzie
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

6.  Sharp decline in rates of community respiratory viral detection among NIH Clinical Center patients during the COVID-19 pandemic.

Authors:  Michele Woolbert; Christine Spalding; Ninet Sinaii; Brooke K Decker; Tara N Palmore; David K Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2022-02-18       Impact factor: 6.520

7.  Impact of COVID-19 Social Distancing Mandates on Gastrointestinal Pathogen Positivity: Secondary Data Analysis.

Authors:  Tanner Palmer; L Scott Benson; Christina Porucznik; Lisa H Gren
Journal:  JMIR Public Health Surveill       Date:  2022-08-24

8.  Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.

Authors:  Lara Marleen Fricke; Stephan Glöckner; Maren Dreier; Berit Lange
Journal:  J Infect       Date:  2020-12-03       Impact factor: 38.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.